Monte Rosa Therapeutics

GLUE

NASDAQHealth Care

Income Statement

Total Revenue$75.62M

Gross Profit$75.62M

Operating Income$-81.11M

EBITDA$-62.01M

EBIT$-70.13M

Pre-tax Income$9.46M

Net Income$-72.7M

Cash Equivalent$144.48M

Total Debt$43.99M

Book Value$201.4M

Book Value Per Share3.60

Return on Equity (ROE)-32.61%

Return on Assets (ROA)-16.57%

Return on Invested Capital (ROI)-32.61%

Net Profit Margin-96.14%

Current Ratio2.40

Quick Ratio2.37

Long-Term Debt / Equitynull